Welcome to Novo Nordisk Science Hub
The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Anders Juul is a clinical professor at the University of Copenhagen, and head of the department of growth and reproduction at Rigshospitalet; Copenhagen, Denmark. He is trained as a Paediatric Endocrinologist and EAA-certified Andrologist.
Professor Juul’s research interests include growth and pubertal disorders as well as genetic, epigenetic, and environmental influences on gonadal and adrenal function throughout life. He has published more than 400 scientific papers (H index 71) and supervised more than 20 PhD students.
In 2015, Professor Juul received the prestigious ESPE (European Society for Paediatric Endocrinology) Research Award.
Prof Jovanna Dahlgren
Pediatric Endocrinology and head of Department of Pediatrics as well as Obstetrics and Gynecology at the Sahlgrenska Academy, Gothenburg, ,
Jovanna Dahlgren is Professor in Pediatric Endocrinology and head of Department of Pediatrics as well as Obstetrics and Gynecology at the Sahlgrenska Academy, Gothenburg. She has a position as senior consultant in endocrinology, diabetes and obesity at Queen Silvia Children´s Hospital. She has been chair of Swedish Paediatric Endocrine association (BES) and a Member of the CPC at European Society of Paediatric Endocrinology (ESPE). She is since a decade the responsible for the Swedish registry for growth hormone treatment in children. Her interest has been to predict the growth response on growth hormone treatment in children born SGA as well as children with rare diseases such as Noonan, Turner, Silver-Russell and Prader-Willi syndrome.
Moreover, her scientific field of interest is perinatal and infancy factors for the metabolic syndrome and obesity. She has coordinated large longitudinal population-based Swedish studies from birth to teenage with different nutritional and growth patterns and mapping changes in the gut and oral microbiota. The focus is to predict the metabolic syndrome in preschool children for early identification and treatment. She is involved in two Swedish national-wide clinical trials on gastric bypass treatment of teenagers.
Read full bio
María Verónica Mericq Guilá
Institute of Maternal and Child Research, Department of Pediatrics, Clinica Las Condes, University of Chile, Santiago, Chile
Dr. Verónica Mericq is Full Professor at the Maternal and Child Research Institute of the Faculty of Medicine of the University of Chile. She completed her residency in paediatrics at the Hospital Luis Calvo Mackenna Paediatric Hospital (University of Chile) and a fellowship in endocrinology at the Maternal and Child Research Institute (Faculty of Medicine, University of Chile).
She has published over 180 publications in specialized journals and has contributed to nine chapters in endocrinology books.
Dr. Mericq has received several awards during her career. She was recognized as the Outstanding International Physician 2021, in recognition of an outstanding contribution and lifelong commitment to the practice of paediatric clinical endocrinology in a country outside of Europe and the basin of the Mediterranean.
Read full bio